According to the actual guidelines, it is not recommended to treat asymptomatic bacteriuria because of the increasing bacterial resistance rates, but it might be useful for both patients and clinicians to be aware of when starting SGLT2 inhibitors and it is important for patients to present themselves to a hospital unit from the early onset of symptoms linked to urinary tract infections. The gene discussed is SLC5A2; the disease is urinary tract infection.